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ABSTRACT
In developed countries, giant strides have been made in reducing mortality due to 
cervical cancer. The success recorded has been largely attributed to effective screening 
programmes. In contrast, the burden and mortality due to this disease is rising in 
developing countries. Access to screening services remains a major challenge for 
the majority of the population at risk. This paper reviews the current demand-side 
barriers to cervical cancer screening in Nigeria and identifies potential solutions. 
Using academic databases and grey literature, a review was carried out to identify 
current screening modalities, barriers to access, and potential solutions. The current 
innovative method for control is early detection and treatment using “See and Treat” 
which involves visual inspection of the cervix with acetic acid (VIA) and cryotherapy. 
Lack of awareness, cost, and availability were identified as major barriers to access. 
Potential solutions feasible in the Nigerian context were categorized as financial and 
non-financial. The potential financial interventions include voucher schemes, conditional 
cash transfers, health equity, community loan funds, and prepayment mechanisms. 
Potential non-financial interventions that would be useful include raising awareness 
via health education and counseling, community participation, community based 
interventions, and pre-payment mechanisms.
Keywords: Cervical cancer; cancer screening; demand; developing countries; access
The misconception that cancer is a disease that can only be diagnosed and 
treated in specialist care facilities is fast shifting grounds with the increasing 
recognition that primary care has a role in all stages of the cancer control 
and care continuum1. The cancer transition, which is a part of the ongoing 
epidemiologic transition faced by developing countries, is projected to lead to 
a 75% increase in cancer incidence in the low and middle income countries 
(LMICs) between the year 2000 and 20202. This has created the double 
burden of cancer, a challenge for governments who are faced with the task 
of deciding which interventions to allocate scarce resources.
Cervical cancer is a preventable malignancy, yet it is the second leading 
cause of cancer deaths in women worldwide. An estimated 266,000 deaths 
from cervical cancer occurred worldwide in 2012, accounting for 7.5% of all 
female cancer deaths3, with nearly 90% of these deaths occurring in low- and 
middle-income countries (LMICs)4. The disproportionate burden of cervical 
cancer in the LMICs gives a dismal picture of 53,300 deaths in Africa, compared 
to the high-income countries (HICs) where the mortality rates from this disease 
is declining2. The decline has been attributed to successful cervical cancer 
screening cytology programmes, which have been integrated as a routine 
part of preventive care in these countries5.
In Sub Saharan Africa, where women are the main income earners in one-
third of households, the economic burden is magnified by the loss of the main 
income earner, besides the pain and suffering imposed by the disease.6 The 
affected families often suffer economic loses imposed by illness and premature 
death. This loss is incurred not only as a result of loss of earnings, but also due 
to the out-of-pocket expenditure required for treatment of this condition. This 
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can lead to catastrophic expenditure, undermining 
financial protection at the household level.
There is a paradigm shift in cancer care and 
control with increasing recognition that cancer can 
be managed at all levels of care, especially at the 
PHC level which is closest to the community. This is 
particularly pertinent with the increasing reliance of the 
health systems on hospitals and specialists, tagged 
“hospital-centrism”, which has greatly undermined 
the core values of PHC creating a major source of 
inefficiency and inequality7. As efforts are made to 
expand universal health coverage (UHC) in the LMICs, 
equity in access to cervical cancer screening is an 
important issue especially in Sub-Saharan Africa, 
where poverty is widespread. It is advocated that 
cervical cancer screening be integrated into already 
existing programs, such as family planning and 
maternal and child health programs using the diagonal 
approach to achieve health system strengthening8. 
The Pink Ribbon/Red Ribbon Initiative advocates the 
integration of breast and cervical cancer screening into 
existing HIV/AIDS programs at primary care level9. 
However, the stigma associated with HIV programs 
and the fact that this will lead to the exclusion of a 
large group of women reiterate the equity issues in 
cervical cancer screening.
Screening is defined as population testing to 
identify early disease or precursors of a disease in 
asymptomatic individuals. It could be targeted at the 
entire population (mass screening) or at individuals 
(selective screening). The WHO criteria as drawn up 
by Wilson and Jungner sets the framework against 
which screening can be judged as appropriate for any 
condition10. Judged against these criteria, cervical 
cancer screening presents an excellent opportunity 
for this otherwise fatal condition to be cured by early 
detection and treatment, thus reducing morbidity and 
mortality from this disease. Prevention of cervical 
cancer involves primary screening by vaccination with 
the HPV vaccine and secondary screening involves 
the use of cytology and other innovative methods as 
discussed subsequently11,12.
The Challenge of Cervical Cancer Screening in 
Low and Middle Income Countries
Many HICs have successfully instituted and sustained 
mass-organised cytology-based screening programs, 
however this remains a challenge for LMICs (due 
to lack of the required infrastructural requirements, 
both human and material, to support cytology-based 
programs)13. Replicating the success of cervical 
cancer screening in the LMICs has been difficult, 
leading to low coverage. In a study of 57 countries 
on the coverage of cervical cancer screening, an 
average of 19% was reported, compared to 63% in 
developed countries, ranging from 1% in Bangladesh 
to 73% in Brazil5.
The failure to successfully replicate the PAP 
smear cytology in LMICs has led to the evaluation 
and adoption of alternative innovative approaches 
to ensure sustainability of prevention programmes. 
These include techniques for testing and treatment 
of precancerous lesions in a single visit, using “direct 
visualization” (either visualization with coloration with 
acetic acid [VIA] or with Lugol’s iodine [VILI]). These 
techniques have been piloted in trials in LMICs, with 
positive results14. The treatment (for women without 
advanced disease) is by cryotherapy — freezing of 
abnormal tissue.
Many studies have evaluated the cost-effectiveness 
of the different health technologies available for 
cervical cancer screening in low-resource settings15-17. 
However, not many studies have focused on access 
to these screening mechanisms and how the health 
system financing mechanism may actually affect the 
uptake of cervical cancer screening.
This paper attempts to address this gap in knowledge 
by reviewing the barriers to access and potential 
solutions to demand-side barriers to access to cervical 
cancer screening in Nigeria. First, an overview of the 
challenges to screening in LMICs and the current 
options available are outlined. This is followed by a 
review of barriers to access and potential solutions. 
Finally, a discussion of the findings and the policy 
implications of integrating cervical cancer care in 
Nigeria’s health system are highlighted.
METHODS
To answer the research questions, a mixed 
research employing a systematic literature review 
was carried out in stages as follows:
A literature review was done systematically. 
Words describing the dimensions of access including 
affordability, availability acceptability, and awareness 
were keyed in as synonyms of access and synonyms 
of developing countries were also used. Academic 
databases used included EMBASE, Global Health, 
and MEDLINE, Social Policy and Practice, Health 
Management Consortium, and Econlit.
Additionally, manual search for the literature 
not available was done by tracing references and 
snowballing. Non-journal and grey literature were 
used in order to ensure a more complete search and 
to access literature not available on the academic 
databases listed above.
The search engines used included Scirus, ELDIS, 
and Google (and Google Scholar). Additionally, Internet 
websites of organizations involved in cancer control 
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policies were searched, including the World Health 
Organization (WHO), and the International Agency 
for Research on Cancer (IARC).
Inclusion Criteria
Any study was included in this review, if:
• The study was performed in developing countries
• The study was published in English
• The study focused on screening
Exclusion Criteria
Any study was excluded if
• The study was done in developed country
• Published in a language other than English
• Published before January 1, 1990
Manual search for literature that was not available 
was done by tracing references and snowballing. 
Non-journal and grey literature was used in order 
to ensure a more complete search and to access 
literature that was not available on the academic 
databases listed above. All references from the 
search engines were downloaded into the Endnotes 
Reference Manager.
Although the study originally set out to explore 
both demand- and supply-side barriers to access and 
possible interventions, the research had to be modified 
to demand-side barriers and interventions due to 
time and space limits. The search was carried out on 
the different interventions to address these barriers 
though not discussed in detail due to space and time 
limits. The key themes of the papers reviewed were 
categorized into demand- and supply-side barriers 
and were discussed along these lines, using the 
dimensions of access as described by Peters et al18.
RESULTS
Options for Cervical Cancer Screening
There are various methods available for screening 
for cervical cancers in LMICs. Such options include:
1. Cytology: This is the traditional method of 
screening using Pap smear. The test involves 
scraping and fixing cervical cells on a slide, 
which is then analyzed by a trained pathologist 
or technician to determine the presence of any 
abnormal cells. However, the unavailability of 
infrastructural requirements, both human and 
material, to support cytology-based programs 
and the time taken for results to be available 
make this an impractical and inefficient option 
in most low-resource settings13.
2. Visual inspection with acetic Acid (VIA): This 
involves naked-eye inspection of the cervix 
under bright light conditions at least 1 min 
after the application of 3.5% diluted acetic 
acid. The test can be carried out by nurses or 
midwives, who check for aceto-white areas in 
the uterine cervix. Several studies documenting 
the efficacy of these options for screening have 
been published11,19. Variants of this include:
2.1 VIA with low-level magnification (VIAM): the 
magnification of (2.4X) using a hand-held 
device is utilized to inspect the cervix. There 
is, however, no evidence that this procedure 
improves the performance of the naked-eye 
visualization test14.
2.2 VIA with Lugol’s Iodine (VILI): visual inspection 
using Lugol’s iodine solution that stains glycogen 
stored in cervical epithelial cells. The yellow-coloured 
changes associated with a positive VILI test result 
are recognized more easily by health workers 
than the acetowhite changes associated with 
VIA. In a large multicentre trial involving almost 
50,000 women, Sankaranarayanan et al. reported 
a higher sensitivity with the VILI compared to 
VIA, varying from 78% to 98% and specificity 
varying from 73% to 91%14. These data suggest 
that VILI is a more sensitive test than VIA.
3. HPV/DNA testing: This method has been found 
to be more objective, preventing more deaths 
in advanced disease and deaths compared 
with the Pap Smear or VIA testing. Evidence 
comes from several studies including a large 
randomized control trial (RCT) carried out in 
rural India20. The self-sampling method, despite 
reducing sensitivity, has been found to be more 
effective.
“See and treat” or refer, integrating either of the VIA 
or its variants or the HPV with immediate cryotherapy 
or LEEP is referred to as the “see-and-treat” approach. 
Integration of the see-and treat with the HPV testing 
programs offers the dual benefits of HPV screening 
to maximize detection and using VIA to triage for 
advanced lesions/cancer, as well as a pelvic exam to 
address other gynaecologic issues11. In an urban-based 
trial in Ghana, a single visit approach was found to 
be efficient, safe and feasible21. A comparison of the 
options available for screening is shown in Table 1.
Barriers to Access
There is no universally accepted definition of 
access to health services and utilization is used as 
a proxy for access in most literature22. However, as 
noted by Peter et al., most authors define access as 
‘the timely use of service according to need’, since 
most definitions would incorporate the idea of realized 
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need18. The framework for discussing dimensions of 
access as described by Peters is shown in Table 2.
In this paper, these barriers to access have 
been categorized into demand-side and supply-side 
barriers23. However, though described separately, 
access barriers are not mutually exclusive and 
often interact24. Demand-side determinants are 
factors influencing the ability to use health services 
at individual, household, or community level, while 
supply-side determinants are aspects inherent to 
the health system that hinder service uptake by 
individuals, households or the community23.
A summary of both demand- and supply-side 
barriers identified is presented in Table 3.
Availability
This is in terms of both human resources and 
the materials required for screening. The majority of 
healthcare workers, though aware, do not recommend 
screening25.
However, by far the greatest challenge to screening 
in Nigeria was identified as lack of awareness26. 
This was both a supply- and demand-side barrier as 
both the healthcare workers and the service users 
showed a lack of awareness. This is similar to other 
studies in other LMICs which document low levels 
of awareness among women27.
As with uptake of most health services, educational 
status is significantly related with uptake of screening28. 
Women with low educational status were less likely 
to use the services29.
Acceptability
Fear of abnormal results, fatalism (Gods will), 
inappropriate beliefs, fear from cancer diagnosis 
and pain related to the procedure were all cited as 
barriers to screening. Qualitative studies highlighted 
the strong socio-cultural context especially in the 
north, where women have to seek permission from 
their husbands before making healthcare decisions30.
Stigma and personal embarrassment is also another 
identified barrier often associated with socio-cultural 
factors, and screening misconceptions affiliated with 
HIV screening31. Availability of a female health worker 
was also cited as most women are embarrassed at 
being examined by a male HCW, besides many men 
would not want their wives examined by a male26,32.
Geographical Accessibility
The geographical location of the centre where 
screening is offered determines the uptake of services. 
Where services are urban-based, more women 
access these services and the rural women lack 
access33. Service location and household location 
relate to distance from the household to the place of 
service delivery. Geographical access barriers can 
also undermine equity in health services utilization; 
people further away from health facilities are less likely 
to access services and have lower utilization rates34.
Affordability
One of the major barriers to uptake is costs of 
service and lack of finances, an important factor, as a 
Table 1: A comparison of the options for Cervical Cancer 
Screening in LMICs.
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Table 2: Dimensions of Access.
Geographical 
Accessibility
The physical distance or travel time 
from service delivery point to the user
Availability Having the right type of care available 




The relationship between the price 
of services (in part affected by their 
costs) and the willingness and ability 
of users to pay for those services, as 
well as be protected from the economic 
consequences of health costs
Acceptability The match between how responsive 
health service providers are to the 
social and cultural expectations of 
individual users and communities
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significant part of the total cost of accessing services 
falls on the demand side25,27,35. The various dimensions 
to accessing health services are summarized in the 
data from the Nigerian National Demographic Health 
Survey 20096. This covers acceptability, affordability, 
geographical, and availability issues.
Potential Solutions for Addressing the Demand 
Side Barriers
To ensure improved access to healthcare 
interventions, especially for the poor and vulnerable, 
the barriers on both supply and demand sides have 
to be addressed36. An overview of the available 
interventions to address these barriers using the 
framework adapted from Jacobs et al. is shown 
in Table 4. The various mechanisms that could 
be used have been categorized into financial and 
non-financial interventions and discussed under 
along the dimensions of access. The financial 
schemes address the dimensions of affordability 
and geographical access, which tend to be related, 
while the non-financial schemes address awareness 
and acceptability barriers37.
Financial Interventions
Demand-side financial interventions include voucher 
schemes, conditional cash transfers, health equity and 
community-loan funds, and prepayment mechanisms38. 
Health vouchers can be used to encourage the use 
of under-consumed services like family planning, 
treatment of infectious diseases, and maternal and 
child health services by subsidizing (fully or partially) 
healthcare costs39. They are different from health 
equity funds, which are third-party mechanisms that 
Table 3: Demand- and Supply-Side Barriers to Access.




• Indirect costs to household
• Transportation
Availability
• Unskilled health workers
• Health worker awareness/offering service
• No equipment /consumable
• Non-integration of health services
• Lack of opportunity (exclusion from services)
• Late or no referral
• Awareness
• Education
• Information on cervical cancer screening
• Waiting times
Affordability
• Costs and prices of services, including informal 
payments
• Private–public dual practices
• Household resources and willingness to pay
• Opportunity costs
• Cash flow within society
Acceptability
• Staff interpersonal skills, including trust
• Availability of female HCW
• Community and cultural preferences
• Stigma
• Lack of health awareness
• Sociocultural Factors
Adapted from Jacob et al.37.
Table 4: Financial and Non-financial Interventions to address 





use of mass 













loan funds for 
transportation
Health subsidies for 
the poor








Adapted from Peters et al18 .
reimburse selected health care providers for services 
delivered to eligible poor.
Conditional cash transfers are monetary transfers 
made to households over a certain time period when 
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complying with certain health behaviour40. Thus 
they can make money available for transport while 
cash transfers make money available for transport 
(geographic accessibility), often deal with low education 
(availability), address household resources and cash 
flow within society (affordability), specifically deal with 
health awareness, and can tackle low self-esteem, 
cultural preferences, and stigma (acceptability)37.
Finally, the pre-payment mechanisms spread the 
risk of health costs. However, while social health 
insurance covers only formal-sector salaried workers, 
community-based health insurance for the informal 
sector tends to be non-inclusive of the poor34. The 
evidence is mixed that community-based health 
insurance improves access to health services. 
This has been documented in systematic reviews, 
observational studies and quantitative studies34,41. 
There is evidence however, that with appropriately 
designed schemes – including strong participatory 
processes, targeted subsidies, facilitation of contribution 
payments, ensuring that services are delivered at 
facilities close to where people live, and effective 
information campaigns – the poorest can be included 
and geographical access barriers minimized34.
Non-financial Interventions
The non-financial interventions which would 
be useful for cervical cancer screening include 
raising awareness, community participation, and 
community-based interventions37,42. Raising awareness 
would involve the use of counselling and provision of 
consumer information on service. This has been found 
to be effective as seen in Bangladesh’s schemes. The 
use of multimedia has been shown to be effective in 
creating awareness as shown in a study in Lagos43,44.
Community-based interventions which can be 
implemented by non-professional health workers, can 
be used to address issues related to service location, 
transport-associated costs and means (geographical 
accessibility), costs of service (affordability), and 
treatment availability45. As these non-professional 
health workers are recruited from within the community, 
many acceptability barriers are reduced for health 
interventions they promote, although the range of 
health interventions that they deliver is limited42.
While supply-side financing aims at strengthening 
the health sector, demand-side financing is directed 
linked to the subsidy, the beneficiary, and the objective 
of the subsidy, leading to improved care-seeking 
behaviour46.
DISCUSSION
The barriers to accessing cervical cancer screening 
in Nigeria reflect the gaps in knowledge by the service 
users, the market failure and informational asymmetry 
that characterize the healthcare sector. The challenges 
of screening are similar to that seen in other LMIC 
countries. There are various innovative technologies 
for screening identified including combination of 
vaccination, screening and see-and-treat. However, 
increasing access to cervical cancer screening 
requires addressing structural barriers related to the 
health system and poverty. The barriers to accessing 
cervical cancer screening resonates the perennial 
barriers to accessing health care services in Nigeria. 
As seen in Figure 1, the biggest barrier to accessing 
health services is financial (55%), distance to health 
facility(37%) and having to take transport(30%)6. This 
makes a strong case for reducing financial barriers 
to accessing health care an imperative for the rural 
poor in Nigeria. These cost issues raise a dire need 
for cervical cancer screening to be made available 
without direct out-of-pocket expenditure which leads 
to substantial health care expenditure for the majority 
of Nigerians.
The cost to households of seeking care, including 
user fees, transportation and lost labour time, is a 
significant factor in health care decisions24. This is 
worse in a situation where there is no apparent ill 
health and people therefore see no reason to visit 
the health care facility.
A potential financial mechanism to improve access 
to screening is the use of vouchers. These have been 
used in Uganda, Pakistan, and India47. The majority 
of these schemes used targeted mechanisms to 
deliver subsidies to individuals, who in the absence 
of the subsidy would likely not have sought care. 
In all programs a positive behavioral response was 
observed, with providers investing voucher revenue to 
attract more clients and improved uptake of services 
documented.
To address the low levels of awareness, counselling 
and provision of consumer information on health 
services, including their availability, intention, and 
associated costs could be used. The use of news 
Figure 1: Barriers to accessing health care services by 
Nigerian families. Adapted from NDHS 20086.
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and electronic media and the internet could serve 
to address acceptability barriers as the expectations 
and needs are tackled.
However, of the potential interventions to addressing 
these barriers, community participation and community-
based interventions and pre-payment mechanisms 
serves as the most versatile mechanisms, offering 
crosscutting interventions that address all the four 
dimensions of access. By helping reduce transport 
costs, improved information about services as well as 
health aspects, reducing opportunity costs, they enable 
access to sufficient cash within the community when 
needed, while addressing household expectations 
and community and cultural preferences48.
Policy Recommendations
Community-based Health Insurance, a form of 
pre-payment mechanism provides one of the most 
feasible means of addressing all four dimensions 
of access. It can reduce exposure to information 
asymmetry (i.e., that they are aware of the benefits 
but the clients are not) by investing in beneficiary 
awareness and education, through control of the 
benefit package (i.e., preparing comprehensive 
packages incorporating cancer screening), and in 
their role as negotiators with health care providers 
over prices of services.
The establishment of functional regional cancer 
registries in the six geopolitical regions to feed into 
the national database will facilitate screening while 
ensuring coverage.
To meet the increased demand from raised 
awareness and the Community-based Health 
Insurance, the mid-level workers, healthcare workers, 
CHEWs currently available in all the states could 
be utilized. Training this category of workers in VIA 
“See and Treat” will lead to task shifting of clinical 
skills. The two-way referral system advocated has 
not been utilized. It would be worth trying a shared 
management where these first level health care 
workers would see and then refer to the higher-level 
facility to strengthen the PHC referral systems. This 
will ensure prompt management of cases beyond 
the scope of the mid-level workers.
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